SGI
1.11
59.7%
GUM
0.14
-22.2%
8IH
0.028
55.6%
MRD
0.038
-20.8%
ALM
0.009
50%
MMR
0.004
-20%
M2R
0.003
50%
RKB
0.004
-20%
LML
0.011
37.5%
RLG
0.004
-20%
QXR
0.004
33.3%
X2M
0.012
-20%
RNX
0.004
33.3%
D3E
0.325
-19.8%
NVA
1.145
33.1%
AUV
0.016
-15.8%
VBS
0.265
32.5%
AVW
0.011
-15.4%
FBM
0.056
30.2%
CC9
0.17
-15%
SDV
0.475
28.4%
PVT
0.017
-15%
AON
0.01
25%
CYQ
0.006
-14.3%
CAV
0.005
25%
DTI
0.012
-14.3%
ENT
0.005
25%
VKA
0.006
-14.3%
FBR
0.005
25%
ATR
0.7
-12.5%
TMX
0.005
25%
NNL
0.19
-11.6%
TMB
0.11
20.9%
DTM
0.04
-11.1%
ZNO
0.076
20.6%
FIN
0.008
-11.1%
OMX
0.1
20.5%
PIM
0.08
-11.1%
BLU
0.006
20%
TEM
0.008
-11.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH